FENG Qing-yun, JIA Yong-yan, ZHOU Chang-ni, et al. Prescription Research of Kangmo Paste[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(10): 15-19.
DOI:
FENG Qing-yun, JIA Yong-yan, ZHOU Chang-ni, et al. Prescription Research of Kangmo Paste[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(10): 15-19.DOI: 10.13422/j.cnki.syfjx.2016100015.
Objective: To observe enhancement of transdermal diffusion rate of Kangmo paste by screening type of substrates and compound penetration enhancers. Method: HPLC was adopted to determine the content of paeoniflorin by taking methanol-0.1% glacial acetic acid (30: 70) as mobile phase and detection wavelength of 234 nm.Utilized skin on the back of SD rats
in vitro percutaneous absorption test was used by Frans diffusion cell method
with cumulative osmotic quantity in 12 h and penetration rate as indexes
which was used to evaluate release and transdermal performance of drug in different types of substrates
in order to select substrate type.Effects of composite permeability dose of azone and propylene glycol on in vitro percutaneous penetration of paeoniflorin in Kangmo paste were investigated by central composite design-response surface methodology. Result: Matrix of O/W emulsion was chosen;when accumulative release rate of paeoniflorin was 72.20% in 12 h
combination of penetration enhancer was 2.4% azone and 1.6% propylene glycol. Conclusion: This optimized substrate and penetration enhancer can significantly improve transdermal rate constant of Kangmo paste.
Paeoniflorin Induces Apoptosis in NSCLC Cells via Activating Hippo Signaling Pathway
Protective Mechanism of Paeoniflorin on Mice with Ulcerative Colitis Based on AMPK/mTOR Autophagy Pathway
Chemical Constituents and Pharmacological Effects of Paeoniae Radix Rubra: A Review
Analysis on Quality Transmitting of Substance Benchmarks of Shaoyao Gancaotang
Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms
Related Author
LI Yan
PENG Liang
JIANG Lifeng
WANG Sheng
WANG Ge
YU Xiaolin
YAO Yulin
DAI Xin
Related Institution
Henan University of Chinese Medicine
Fuwai Central China Cardiovascular Hospital/Henan Provincial People's Hospital
The Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital
School of Clinical Medicine,Changchun University of Chinese Medicine
School of Pharmacy,Changchun University of Chinese Medicine